C07C 233 - Carboxylic acid amides

Patents for C07C 233 - Carboxylic acid amides (28,881)
12/2001
12/13/2001	WO2001094357A1 Antitumoral compounds
12/13/2001	WO2001094295A1 Substituted stilbenes as glucose uptake enhancers
12/13/2001	WO2001094278A1 Chiral monophosphites as ligands for asymetrical synthesis
12/13/2001	WO2001093653A2 Ester quaternary mixtures
12/13/2001	WO2001068599A3 Dosing form for reagents, use of said dosing form in organic chemical synthesis and production of said dosing form
12/13/2001	WO2001034129A3 Heteroatom-interrupted analogs of 15-hydroxyeicosatetraenoic acid and methods of use
12/13/2001	US20010051750 Making a 2-fluoro-2-chlorocyclopropanecarboxylic acid derivative stereoselectively in high yield by reacting a diazoacetic acid derivative with 1-fluoro-1-chloroethylene using metal catalyst having chiral ligands
12/13/2001	US20010051657 Malonamic acids and derivatives thereof as thyroid receptor ligands
12/13/2001	US20010051648 Administering to a mammal for the treatment of dry eye or other disorders requiring the wetting of the eye a heteroatom such as nitrogen, oxygen or sulfur interrupted hydroxyeicosatetraenoic acid related compounds
12/13/2001	US20010051158 A monoclonal antibody that specifically recognizes a stimulant or hallucinogenic drug of abuse or a metabolite, selected from d-methamphetamine, d-amphetamine, 3,4-methylenedioxymethamphetamine or derivatives
12/13/2001	DE10028453A1 Esterquat mixtures, used in production of cosmetic formulations for hair and skin contain esterquats derived from fatty acids with different chain lengths, e.g. coconut fatty acids and stearic and/or behenic acid
12/13/2001	DE10027505A1 Asymmetric hydrogenation, hydrosilylation, hydroboration, hydroformylation and hydrocyanation of prochiral olefins, ketones and ketimines uses transition metal catalysts containing chiral monophosphite as ligand
12/13/2001	CA2411340A1 Substituted stilbenes as glucose uptake enhancers
12/13/2001	CA2410410A1 Chiral ligands for asymmetric catalysis
12/13/2001	CA2410409A1 Antitumoral compounds
12/12/2001	EP1161481A1 Optically active linear polymer used as ligand in the preparation of metallic complexes designed for asymmetric catalysis
12/12/2001	EP1161412A1 Nuclear receptor arylating compounds
12/12/2001	EP1161233A2 Lxr modulators
12/12/2001	EP0858992B1 Process for producing halogenated cyclopropane derivatives
12/12/2001	EP0804279B1 Amphiphilic compounds with at least two hydrophilic and at least two hydrophobic groups based on amides
12/12/2001	EP0781126B1 Derivatives of 2-amino-1,2,3,4-tetrahydro-naphthalene active on the cardiovascular system
12/12/2001	EP0765865B1 2-acylaminopropanol compound and medicinal composition
12/12/2001	CN1325847A Compound with electron providing and receiving functional groups
12/12/2001	CN1325845A Solidized hybridized vinyl ether containing electron providing compound
12/11/2001	US6329548 Aqueous stable lysine solution
12/11/2001	US6329409 Amine derivatives and skin preparations for external use containing the same
12/11/2001	US6329405 As ileal bile acid transporter inhibitor, for therapy of hyperlipemia
12/11/2001	US6329395 Urea derivatives for treating an eating disorder or diabetes comprising administering an effective amount of a compound of claim 1 to a mammal
12/11/2001	US6329362 Modulation cell adhesion the compounds are able to inhibit the binding of alpha 4 integrins to their ligands and are of use in the prophylaxis and treatment of immune or inflammatory disorders.
12/11/2001	US6329360 Hetero-linked phenylglycinolamides
12/06/2001	WO2001092218A2 Polyamine analogues as therapeutic and diagnostic agents
12/06/2001	WO2001092208A1 Metal-catalysed carboxymethylation in the presence of a promoter
12/06/2001	WO2001092207A1 Process for the production of nitrogen compounds
12/06/2001	WO2001092205A2 Stabilization of amido acids with antioxidants
12/06/2001	WO2001092201A1 Substituted phenylpropionic acid derivatives
12/06/2001	CA2410935A1 Novel polyamine analogues as therapeutic and diagnostic agents
12/05/2001	EP1159261A2 Antizyme modulators and their use
12/05/2001	EP1159260A1 Novel compounds and compositions as protease inhibitors
12/05/2001	EP1159258A1 Amide compounds for the potentiation of cholinergic activity
12/05/2001	EP1159255A2 Bis(1,3-dihydroxy-prop-2-yl)amine and derivatives thereof in the manufacture of polymers
12/05/2001	EP1158971A1 Gardos channel antagonists
12/05/2001	EP0970195A4 Fatty-acid amide hydrolase
12/05/2001	CN1325380A Benzene derivatives and medical use thereof
12/05/2001	CN1325377A New esters derived from substituted phenyl-cyclohexyl compounds
12/05/2001	CN1325376A Novel compounds and medicinal use thereof
12/05/2001	CN1324909A Electronic donor compound capable of solidifying
12/05/2001	CN1075799C Monomers and composition which can be crosslinked and crosslinked polymers
12/04/2001	US6326517 Reactin an aromatic compound with carbon monoxide and ammonia
12/04/2001	US6326510 Skin disorders; anticancer agents
12/04/2001	US6326398 Oxamic acids and derivatives as thyroid receptor ligands
12/04/2001	US6326369 Bicyclic quinone compounds, their production and use
11/2001
11/29/2001	WO2001090106A2 Tryasolyl tropane derivatives as ccr5 modulators
11/29/2001	WO2001090052A1 Cyclic amino acid derivatives useful as pharmaceutical agents
11/29/2001	WO2001035950A3 Benzamide therapeutics and methods for treating inflammatory bowel disease
11/29/2001	US20010047119 Layered structure effecting under mild conditions organo reactions, i.e. dehydration of alcohols to olefins or ethers, dehydrogenation of aldehydes or ketones to alcohols, olefin isomerization, alkylations, hydrogen shift reactions and more
11/29/2001	US20010046975 Fungicides for the control of take-all disease of plants
11/29/2001	DE10026108A1 Preparation of amino derivatives of CH acid compounds comprises nitrosation and catalytic hydrogenation, with the nitrosation being in the presence of an excess of a carboxylic anhydride
11/29/2001	DE10024939A1 Neue Diphenylmethanderivate für Arzneimittel New diphenylmethane derivatives for pharmaceuticals
11/29/2001	CA2409768A1 Cyclic amino acid derivatives useful as pharmaceutical agents
11/28/2001	EP1158008A2 Curable hybrid electron donor compounds containing vinyl ether
11/28/2001	EP1157006A2 Phenyl- and pyridinyl derivatives as neurokinin 1 antagonists
11/28/2001	EP1157002A1 1,2,3,4-tetrahydro-1-naphthalenamine compounds useful in therapy
11/28/2001	EP1157001A1 Oxamic acids and derivatives as thyroid receptor ligands
11/28/2001	EP1157000A1 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of diabetic retinopathy
11/28/2001	EP0918745B1 Catalytic preparation process of n-acylglycine derivatives
11/28/2001	CN1324344A N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them
11/27/2001	US6323365 For therapy of convulsions and epilepsy, and for the treatment of pain and migraine, bipolar disorder
11/27/2001	US6323229 Compounds are useful psychotherapeutics and are potent agonists and/or antagonists of the serotonin 1a (5-ht 1a) and/or serotonin 1d (5-ht 1d) for treatment of hypertension, depression, generalized anxiety disorder
11/27/2001	US6323163 Fluorocompound, lubricant, surface modifier, lubricating film, magnetic recording medium, and magnetic recording device
11/22/2001	WO2001087866A1 Cyclohexyl derivatives and their use as therapeutic agents
11/22/2001	WO2001087838A1 Cyclohexane derivatives and their use as therapeutic agents
11/22/2001	WO2001087822A1 Novel phenyl-propargylether derivatives
11/22/2001	WO2000035879A8 3-phenyl-2,6-dioxopiperidin-3-yl propionamide derivatives and method for preparing same
11/22/2001	US20010044405 Alkanolamides
11/22/2001	US20010043942 Aqueous stable lysine solution
11/22/2001	CA2410077A1 Cyclohexyl derivatives and their use as therapeutic agents
11/22/2001	CA2408849A1 Cyclohexane derivatives and their use as therapeutic agents
11/21/2001	EP1156049A1 Substituted heterocyclic compounds, their process of preparation and pharmaceutical compositions containing them
11/21/2001	EP1156036A2 Compounds with electron donor and electron acceptor functionality
11/21/2001	EP1156034A2 Curable electron donor compounds
11/21/2001	EP1156033A1 Process for producing acidic n-(long-chain acyl)amino acid
11/21/2001	EP1156032A1 Optically active amino acid derivatives and processes for the preparation of the same
11/21/2001	EP1156031A1 Novel compound, polymer prepared from the compound, and composition comprising the polymer
11/21/2001	EP1155616A1 Process for the preparation of (N-phenylacetyl-N-2,6-xylil)methyl alaninate
11/21/2001	EP1154991A1 Salicylamide-lanthanide complexes for use as luminescent markers
11/21/2001	EP1154990A1 Phthalamide-lanthanide complexes for use as luminescent markers
11/21/2001	EP1154987A1 Phenylalaninol derivatives
11/21/2001	EP1154985A1 Process for the industrial production of beta-hydroxyalkyl amides
11/21/2001	EP1154984A1 Inhibitors for uptake of serotonine, dopamine or norepinephrine
11/21/2001	EP0952974B1 Biphenyl derivatives substituted by an aromatic or heteroaromatic radical and pharmaceutical and cosmetic compositions containing same
11/21/2001	CN1323291A Diaminopropionic acid derivatives
11/21/2001	CN1323289A Aminoalcohol derivatives and their use as beta 3 adrenergic agonists
11/21/2001	CN1323203A FC receptor modulators and uses thereof
11/21/2001	CN1322711A Prepn of optically active chloromycetin
11/21/2001	CN1322526A Compound for treating female sexual dysfunction
11/21/2001	CN1322524A Use of pentanoate derivant
11/21/2001	CN1075090C UV absorbers, their preparation and the use thereof
11/21/2001	CN1075066C Taxanes having an alkyl substituted side-chain and pharmaceutical compositions containing them
11/21/2001	CN1075060C Alkoxy-alkyl-substituted 1-H-3-aryl-pyrrolidine-2.4-diones uses as herbicides and pesticides
11/21/2001	CN1075059C Colchicine derivatives and its therapeutical use

1 ... 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 ... 289